Michael M. Gottesman

65.0k citations
408 papers · 53.6k indexed · 20 hit papers · h-index 101
Topics
Drug Transport and Resistance Mechanisms (215 papers)RNA Interference and Gene Delivery (61 papers)Cancer therapeutics and mechanisms (53 papers)
Partner nations
United StatesJapanIsrael

In The Last Decade

Michael M. Gottesman

403 papers receiving 52.3k citations

Hit Papers

Multidrug resistance in cancer: role of ATP–depend...19852026199820122002200619872002200610002.0k3.0k4.0k

Peers

Michael M. Gottesman
Comparison fields: 5 of 173
  • Oncology 32.9k
  • Molecular Biology 27.8k
  • Pediatrics, Perinatology and Child Health 7.8k
  • Infectious Diseases 5.9k
  • Surgery 4.9k
Replace Ira Pastan with:
Ira Pastan United States
Susan E. Bates United States
Piet Borst Netherlands
Victor Ling Canada
Suresh V. Ambudkar United States
Alfred H. Schinkel Netherlands
Zhe‐Sheng Chen United States
John C. Reed United States
Takashi Tsuruo Japan
Godefridus J. Peters Netherlands
Michael M. Gottesman relative to Ira Pastan United States Ira Pastan's profile →
Citations per field
00.5×1.5×
Ira Pastan · 1×
Citations per year

Countries citing papers authored by Michael M. Gottesman

Since Specialization
Citations

This map shows the geographic impact of Michael M. Gottesman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Gottesman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Gottesman more than expected).

Fields of papers citing papers by Michael M. Gottesman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Gottesman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Gottesman. The network helps show where Michael M. Gottesman may publish in the future.

Co-authorship network of co-authors of Michael M. Gottesman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Gottesman. A scholar is included among the top collaborators of Michael M. Gottesman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Gottesman. Michael M. Gottesman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 22
4 5
5
Revisiting the role of ABC transporters in multidrug-resistant cancerbreakdown →
1382
6 19
7 293
8 39
9 48
10 96
11 84
12 40
13 87
14 31
15 124
16 194
17
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificitybreakdown →
1912
18 141
19
Localization of Alexa-conjugated cisplatin in cisplatin-resistant cell lines
1
20
Molecular genetics of mammalian cells
30

About Michael M. Gottesman

Michael M. Gottesman is a scholar working on Oncology, Molecular Biology and Physiology, having authored 408 papers that have together received 53.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (215 papers), RNA Interference and Gene Delivery (61 papers) and Cancer therapeutics and mechanisms (53 papers). The work is most often cited by research in Oncology (32.9k citations), Molecular Biology (27.8k citations) and Pediatrics, Perinatology and Child Health (7.8k citations). Michael M. Gottesman has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include Ira Pastan, Susan E. Bates, Suresh V. Ambudkar, Tito Fojo, Kazumitsu Ueda, I Pastan, Matthew D. Hall, Antonio Tito Fojo, Gergely Szakács and Chava Kimchi‐Sarfaty. Their work appears in journals such as Science, New England Journal of Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026